CollaGenex Stock Up on Oracea Application
3rd Oct 2005, 21:50 GMT
Shares of CollaGenex Pharmaceuticals set a new 52-week high as the skin products maker announced that the FDA accepted the submission of its marketing application for rosacea treatment Oracea.
CollaGenex Stock Up on Oracea Application related news:
- CollaGenex Pharmaceuticals' New Drug Application for ORACEA Accepted for Review by FDA — Financial News News from StratCenter.com
- FDA will consider CollaGenex skin drug — Latest news from Philadelphia Business Journal
- Market Pulse: CollaGenex: FDA to review application for rosacea treatment — Pharmaceuticals News from StratCenter.com
- FDA to review CollaGenex rosacea treatment — Pharmaceutical Business Review Online
- SEC moves forward on Nasdaq application (Reuters) — Yahoo! News: Stock Markets News
- How AJAX kills the application server — ZDNet Blogs
- American Stock Exchange Lists Common Stock of Uroplasty — Operations-Related News from StratCenter.com
- Need for speed -- Eliminating performance bottlenecks — developerWorks : Java technology : Technical library
- Build a dynamic Derby application — developerWorks : Java technology : Technical library
- What if You Trusted Stock Tip Spam? — Broadbandreports.com
Latest news from Financial News News from StratCenter.com:
- TRADE NEWS: Agilent Technologies Introduces High-Speed, High-Volume USB Multifunction Data Acquisition Modules, Chassis
- Bio-Rad Closes Buy of Ciphergen Unit
- The LGL Group Reports Q3 Earnings
- Analogic CEO to retire
- Analogic CEO Plans to Retire
- Meade Instruments Contracts with Leading Asian Outsource Manufacturing Firm
- JMAR Receives Nasdaq Delisting Notice
- Analogic Corp Announces Mgmt Changes
- Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems
- Agilent to buy Switzerland's Acqiris